April 19, 2021
More than 97% of surveyed councilors and associates from the International Eczema Council agreed that therapeutic patient education should play an important role in atopic dermatitis management, according to a study published in JAAD International.
“Publications have shown the positive effect of therapeutic patient education on the course of the disease, the prevention of complications, and the autonomy and quality of patient life,” researchers wrote. “Survey respondents agreed that therapeutic patient education can improve the quality of patient care and patient satisfaction with care.”
The study included 42 International Eczema Council councilors and associates who responded to a 28-question electronic survey. Participants were mostly hospital-based clinicians from Asia, Australia, Canada, Europe, India, South America, the Middle East, the United Kingdom, and the United States. Nearly a third saw more than 100 patients with atopic dermatitis per month.
According to the study, 97.5% or respondents agreed that therapeutic patient education has a key role in the management of persistent, treatment-refractory atopic dermatitis. Some 82.9% believed every patient with atopic dermatitis, regardless of severity, could benefit from therapeutic patient education.
Eight out of 10 respondents reported providing tools for therapeutic patient education, such as handouts, videos, photos, and order sets, to patients and caregivers, according to the study. Many said they also provided such materials to physicians, residents, nurses, pharmacists, and other allied health care professionals.
“They concluded that therapeutic patient education can improve the quality of patient care and patient satisfaction with care,” researchers wrote, “and that there is much to be done in this area compared with the advances in therapeutic patient education for other chronic conditions.”
Eichenfield LF, Kusari A, Han AM, et al. Therapeutic education in atopic dermatitis: a position paper from the International Eczema Council. JAAD International. 2021;3:8-13.